These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3884339)

  • 21. Reversal of liver failure in rats by ultraviolet-irradiated hepatocyte transplantation.
    Kawai Y; Price JB; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):989-91. PubMed ID: 3274437
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversal of experimental acute hepatic failure in the rat.
    Makowka L; Falk RE; Rotstein LE; Falk JA; Nossal N; Langer B; Blendis LM; Phillips MJ
    J Surg Res; 1980 Dec; 29(6):479-87. PubMed ID: 7001150
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
    Keegan-Rogers V; Wu GY
    Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The model of D-galactosamine-induced injury of rat hepatocytes in primary culture.
    Kucera O; Lotková H; Kand'ár R; Hézová R; Muzáková V; Cervinková Z
    Acta Medica (Hradec Kralove); 2006; 49(1):59-65. PubMed ID: 16696445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tryptophan metabolism in D-galactosamine-induced liver injury.
    Mizoguchi Y; Kodama C; Sakai M; Sakagami Y; Kobayashi K; Morisawa S; Yamamoto S; Yamada J
    Gastroenterol Jpn; 1988 Oct; 23(5):534-7. PubMed ID: 2463950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular transplantation in rats with toxic induced liver failure: results of iso-, allo- and xenografts.
    Contini S; Pezzarossa A; Sansoni P; Mazzoni MP; Botta GC
    Ital J Surg Sci; 1983; 13(1):25-30. PubMed ID: 6347966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental study of fetal liver transplantation.
    Tsuji K; Moriya K; Akiyama M
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):225-32. PubMed ID: 3914745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of DBcAMP on galactosamine-induced acute liver failure].
    Kakisaka A; Kasai S; Sawa M
    Nihon Geka Gakkai Zasshi; 1986 May; 87(5):581. PubMed ID: 3012316
    [No Abstract]   [Full Text] [Related]  

  • 29. Granulocyte colony-stimulating factor treatment ameliorates liver injury and improves survival in rats with D-galactosamine-induced acute liver failure.
    Zhang L; Kang W; Lei Y; Han Q; Zhang G; Lv Y; Li Z; Lou S; Liu Z
    Toxicol Lett; 2011 Jul; 204(1):92-9. PubMed ID: 21550386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte transplantation and the differentiation fate of host oval cells in acute severe hepatic injury.
    Yu CH; Chang MH; Chien CS; Chen YH; Chang MF; Chen HL
    Cell Transplant; 2010; 19(2):231-43. PubMed ID: 19906331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal liver allo- and xenotransplantation in acute and chronic hepatic failure.
    Sano N; Matsuno N; Sugimoto A; Seiki K; Tsuji K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2360-1. PubMed ID: 2652767
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors effective in reducing rat mortality due to acute liver failure as induced by D-galactosamine poisoning.
    O'Neill PL; Blanc PL; Sutherland DE
    J Surg Res; 1984 Apr; 36(4):371-6. PubMed ID: 6708501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encapsulated hepatocyte transplantation for the treatment of D-galactosamine-induced acute hepatic failure in rats.
    Hirai S; Kasai S; Mito M
    Eur Surg Res; 1993; 25(4):193-202. PubMed ID: 8330636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of small-intestinal factors on hepatocyte development and modification of chemical agent-induced hepatopathy in rat.
    Takahashi N; Ohnaka S
    Int J Tissue React; 1991; 13(4):207-14. PubMed ID: 1821414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.
    Sommer BG; Sutherland DE; Matas AJ; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):578-84. PubMed ID: 377697
    [No Abstract]   [Full Text] [Related]  

  • 36. [Protective effect of cresacin in D-galactosamine-induced acute experimental hepatitis].
    Korda MM
    Ukr Biokhim Zh (1978); 1998; 70(1):63-8. PubMed ID: 9848142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of fibronectin in galactosamine-induced liver failure in rats.
    Moriyama T; Aoyama H; Ohnishi S; Imawari M
    Hepatology; 1986; 6(6):1334-9. PubMed ID: 3793010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxin.
    Shiratori Y; Moriwaki H; Muto Y; Onishi H; Kato M; Asano F
    Gastroenterol Jpn; 1989 Dec; 24(6):640-5. PubMed ID: 2558038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicity of D-galactosamine for rat hepatocytes in monolayer culture.
    Tran-Thi TA; Phillips J; Falk H; Decker K
    Exp Mol Pathol; 1985 Feb; 42(1):89-116. PubMed ID: 2857129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portal hemodynamic changes after hepatocyte transplantation in acute hepatic failure.
    Yu CH; Chen HL; Chen WT; Ni YH; Lin YL; Chang MH
    J Biomed Sci; 2004; 11(6):756-63. PubMed ID: 15591772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.